Cargando…
Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers
Triple-negative breast cancers (TNBCs) are heterogeneous and metastatic, and targeted therapy is highly needed for TNBC treatment. Recent studies showed that extracellular vesicles (EV) have great potential to deliver therapies to treat cancers. This study aimed to develop and evaluate a natural com...
Autores principales: | Si, Yingnan, Chen, Kai, Ngo, Hanh Giai, Guan, Jia Shiung, Totoro, Angela, Zhou, Zhuoxin, Kim, Seulhee, Kim, Taehyun, Zhou, Lufang, Liu, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781632/ https://www.ncbi.nlm.nih.gov/pubmed/35057042 http://dx.doi.org/10.3390/pharmaceutics14010146 |
Ejemplares similares
-
Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma
por: Chen, Kai, et al.
Publicado: (2022) -
Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer
por: Si, Yingnan, et al.
Publicado: (2021) -
Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
por: Si, Yingnan, et al.
Publicado: (2021) -
Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy
por: Si, Yingnan, et al.
Publicado: (2020) -
Antibody–Drug Conjugate to Treat Meningiomas
por: Chen, Kai, et al.
Publicado: (2021)